Editorial Team

Chief Editor

Joanna Brougher, Journal of Commercial Biotechnology, United States

Editor at Large

Dr. Arthur Anthony Boni, John R. Thorne Distinguished Career Professor of Entrepreneurship, Emeritus; Tepper School of Business at Carnegie Mellon, United States

Associate Editors

Arlen Meyers, Professor, Department of Otolaryngology, Dentistry and Engineering, University of Colorado Denver, United States

Dr. Thomas J Siepmann, Siepmann IP Consulting, PLLC

Editorial Advisory Board

Mark J. Ahn, Principal, Pukana Partners, Ltd., United States

Dr. Arthur Anthony Boni, John R. Thorne Distinguished Career Professor of Entrepreneurship, Emeritus; Tepper School of Business at Carnegie Mellon, United States

Walter Bratic, Managing Director, Overmont Consulting LLC, United States

Joanna Brougher, Journal of Commercial Biotechnology, United States

Ananda Mohan Chakrabarty, University of Illinois at Chicago, United States

Vijay Chandru, Chairman & CEO, Strand Life Sciences Pvt Ltd, India and Consulting Professor, ISL/EE, Stanford University, United States

James Class, Director, Global Public Policy, Merck, United States

Jeremy Laurence Curnock Cook, Executive Chairman, Bioscience Managers Limited, United Kingdom

Iraj Daizadeh, Senior Manager, Amgen Inc, United States

Mitch DeKoven, Principal, Health Economics & Outcomes Research, Real-World Evidence Solutions, IMS Health, United States

Spencer G. Feldman, Partner, Olshan Frome Wolosky LLP, United States

Sharon Finch, Director, Medius Associates, United Kingdom

Hernan Garrido-Lecca, Chairman and CEO Bioinvest; Professor of Economics and Public Policy, Universidad de San Martín de Porres, Lima Peru and Former Minister of Health, Peru

Dave Jensen, Managing Director, Kincannon & Reed Global Executive Search, United States

Alan Jonason, Senior Analyst, Clearpoint Strategy Group LLC, United States

Kenneth Kaitin, Director, Tufts Center for the Study of Drug Development and Professor of Medicine, Tufts University School of Medicine, United States

John Khong, Owner, Niche Medical, J & M Technologies, Cell Sciences; Adjunct faculty, LKC Business School, Singapore management University, Singapore

Thomas J. Kowalski, Attorney at Law, Vedder Price P.C., United States

Leonard Lerer, Sudarskis & Partners, United Arab Emirates

Weijun Li, Senior Research Scientist, Global Biological Development, Bayer HealthCare Pharmaceuticals, United States

Bryan A. Liang, Professor of Anesthesiology & Director San Diego Center for Patient Safety, University of California San Diego School of Medicine; Professor of Law & Executive Director, Institute of Health Law Studies, California Western School of Law, United States

Ken Malone, Principal, Early Charm Ventures

Henry I. Miller, Senior Fellow, Pacific Research Institute, San Francisco, California, United States

Dr. Stefan Michael Miller, Partner, Kirkland & Ellis LLP, United States

Sudha Nair, Director, Global Business Development, Apotex Fermentation Inc., Canada

Robin Nott, Chair of the Laws Committee, Licensing Executives Society Britain and Ireland, United Kingdom

Mark Paris, Director, Bioinformatics & Molecular Biology Vaccinex, Inc.

Peter Pitts, President, Center for Medicine in the Public Interest

Meir Perez Pugatch, Managing Director Pugatch Consilium; Chair, Division of Health Systems Administration, School of Public Health, University of Haifa, Israel

Anthony J Russo, Chairman and CEO, Russo Partners, United States

Gene Rzucidlo, Partner at Hershkovitz & Associates

Stephen M. Sammut, Senior Fellow, Wharton Health Care Systems and Entrepreneurial Programs and Venture Partner, Burrill & Company, United States

Simon Shohet, Practice Director, Pope Woodhead & Associates Ltd, United Kingdom

Grant H Skrepnek, Associate Professor, The University of Oklahoma Health Sciences Center, United States

Ernest Smith, Senior Vice President of Research & Chief Scientific Officer, Vaccinex, Inc.

Anthony Stevens, Director, Medical Options, United Kingdom

Philip Neal Sussman, Managing Partner, The Channel Group LLC, United States

Michael Weiner, CEO, Technology Innovations, United States

Michael Vitale, Director of Commercialisation, Monash Asia-Pacific Centre for Science and Wealth Creation, Monash University, Australia


Yali Friedman, Journal of Commercial Biotechnology